Backs FY26 adjusted EBITDA view at least $530M. The company said, “The Company reaffirmed its outlook for 2026 revenues to be in the range of $3.35 billion to $3.45 billion and Adjusted EBITDA of at least $530 million.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SGRY:
- Surgery Partners Inc. (SGRY) Q1 Earnings Cheat Sheet
- Surgery Partners price target lowered to $15 from $16.25 at Jefferies
- Ortelius says ‘it’s time for substantial change’ at Surgery Partners
- Surgery Partners price target lowered to $20 from $28 at TD Cowen
- Surgery Partners price target lowered to $17 from $19 at Mizuho